We are one of only a few CDMOs in the world that services sterile fill, device manufacture, and final assembly in one geographic location. We offer large commercial, niche commercial, and small clinical scale filling.
Bridgeton highlights
100 M+ Unit Initial Capacity
~ 155 K+ SQ. FT. cGMP Footprint, With 13K+ sq. ft. of Uncommitted Space for Custom Build-Out
3 Isolator High-Speed Filling Lines, with Utilities to Support Up to 7 Lines
1 MicroBatch Syntegon Isolated Filling Line for Batch Sizes <2,500
~ 300 /MIN Line Speed Cartridges and Syringes & 400/min Line Speed for Vials
$ 200 M+ Investment
$ 150 M+ Investment
100 M+ Unit Initial Capacity
~ 155 K+ SQ. FT. cGMP Footprint, With 13K+ sq. ft. of Uncommitted Space for Custom Build-Out
3 Full Isolated Filling Lines, with Utilities to Support Up to 7 Lines
1 MicroBatch Syntegon Isolated Filling Line for Batch Sizes <2,500
~ 300 /MIN Line Speed Cartridges and Syringes & 400/min Line Speed for Vials
Unmatched integration across injectable capabilities
Shipping products and supplies between providers increases carbon footprint and product cycle time, complicating logistics and introducing opportunities for breakdowns during multiple handoffs. By integrating our sterile injectable operations across our St. Louis facilities, our partners benefit from formulation through final packaging.
A sneak peek inside our Bridgeton facility
Watch this video for an overview of our new facility, with an inside look at its construction and features.
Get a more detailed view of our capabilities and capacity.
Elevating the standards for aseptic fill-finish
We strategically use technology at our Bridgeton facility to ensure efficiency and compliance. Each process is tailored to our partners’ needs, informed by over half a century of as one of the top sterile fill-finish companies.
Isolator integration for Annex 1 compliance
This is one of only a few facilities globally that is entirely Annex 1 compliant. We achieve this through the use of the latest isolator technology, including both traditional glove access and gloveless/robotic options.
Streamlining changeover through automation
Using an automated PUPSIT system integrated into the filling machines, we ensure process controls throughout filling. Each suite operates independently, allowing separate maintenance and reducing downtime to keep your production on schedule. Automated controls allow us to track individual vials and ensure quality at every point in the process.
At the forefront of AI implementation
We use artificial intelligence (AI) to break processes down into steps and evaluate each one for operator safety and risk reduction. We are continually implementing the latest technology with a focus on patient safety and process efficiency.
Designed from the ground up for today’s challenges
Our design principles informed every aspect of our facility construction, allowing us to better service our partners’ needs:
Combine forces with a comprehensive CDMO partner
Ready to leverage the value of our Bridgeton facility to support your product? Reach out to learn how we can support you.